AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
USE OF DEXRAZOXANE AND OTHER STRATEGIES TO PREVENT CARDIOMYOPATHY ASSOCIATED WITH DOXORUBICIN-TAXANE COMBINATIONS
Authors: SPARANO JA
Citation: Ja. Sparano, USE OF DEXRAZOXANE AND OTHER STRATEGIES TO PREVENT CARDIOMYOPATHY ASSOCIATED WITH DOXORUBICIN-TAXANE COMBINATIONS, Seminars in oncology, 25(4), 1998, pp. 66-71
TENASCIN PATTERN OF EXPRESSION AND ESTABLISHED PROGNOSTIC FACTORS IN INVASIVE BREAST-CARCINOMA
Authors: ISKAROS BF HU XP SPARANO JA FINEBERG SA
Citation: Bf. Iskaros et al., TENASCIN PATTERN OF EXPRESSION AND ESTABLISHED PROGNOSTIC FACTORS IN INVASIVE BREAST-CARCINOMA, Journal of surgical oncology, 68(2), 1998, pp. 107-112
OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY
Authors: SPARANO JA HU XP WIERNIK PH SARTA C REDDY DM HANAU L HENRY DH
Citation: Ja. Sparano et al., OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY, Journal of the National Cancer Institute, 89(4), 1997, pp. 301-307
OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY
Authors: SPARANO JA HU XP WIERNIK PH SARTA C REDDY D HANAU L
Citation: Ja. Sparano et al., OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 87-87
INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: SPARANO JA WIERNIK PH HU XP SARTA C DOMENECH G CIOCZEK H RACEVSKIS J
Citation: Ja. Sparano et al., INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 88-88
URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY
Authors: KABAT GC CHANG CJ SPARANO JA SEPKOVIC DW HU XP KHALIL A ROSENBLATT R BRADLOW HL
Citation: Gc. Kabat et al., URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY, Cancer epidemiology, biomarkers & prevention, 6(7), 1997, pp. 505-509
PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
Authors: SPARANO JA NEUBERG D GLICK JH ROBERT NJ GOLDSTEIN LJ SLEDGE GW WOOD W
Citation: Ja. Sparano et al., PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1880-1884
URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY
Authors: KABAT GC CHANG CJ SPARANO JA SEPKOVIC DV HU XP KHALIL A ROSENBLATT R BRADLOW HL
Citation: Gc. Kabat et al., URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY, American journal of epidemiology, 145(11), 1997, pp. 207-207
PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA
Authors: SPARANO JA ROBERT N SILVERMAN P LAZARUS H MALIK U VENKATRAJ U SARTA C
Citation: Ja. Sparano et al., PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA, Journal of clinical oncology, 14(9), 1996, pp. 2576-2583
PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA
Authors: SPARANO JA WIERNIK PH HU XP SARTA C SCHWARTZ EL SOEIRO R HENRY DH MASON B RATECH H DUTCHER JP
Citation: Ja. Sparano et al., PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(11), 1996, pp. 3026-3035
PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292
Authors: SPARANO JA LIPSITZ S WADLER S HANSEN R BUSHUNOW PW KIRKWOOD J FLYNN PJ DUTCHER JP BENSON AB
Citation: Ja. Sparano et al., PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292, American journal of clinical oncology, 19(6), 1996, pp. 546-551
STEREOTAXIC CORE NEEDLE-BIOPSY OF MULTIPLE SITES IN THE BREAST - EFFICACY AND EFFECT ON PATIENT-CARE
Authors: ROSENBLATT R FINEBERG SA SPARANO JA KALEYA RN
Citation: R. Rosenblatt et al., STEREOTAXIC CORE NEEDLE-BIOPSY OF MULTIPLE SITES IN THE BREAST - EFFICACY AND EFFECT ON PATIENT-CARE, Radiology, 201(1), 1996, pp. 67-70
APOPTOSIS IN INVASIVE BREAST-CARCINOMA - CORRELATION WITH GRADE, HORMONE RECEPTORS, AND SURVIVAL
Authors: ISKAROS B HU X SPARANO JA FINEBERG S
Citation: B. Iskaros et al., APOPTOSIS IN INVASIVE BREAST-CARCINOMA - CORRELATION WITH GRADE, HORMONE RECEPTORS, AND SURVIVAL, Laboratory investigation, 74(1), 1996, pp. 87-87
DOES NEOADJUVANT CHEMOTHERAPY (NAC) ALTER BIOLOGICAL MARKERS IN LOCALLY ADVANCED BREAST-CANCER (LABC)
Authors: SENO R SPARANO JA FINEBERG S
Citation: R. Seno et al., DOES NEOADJUVANT CHEMOTHERAPY (NAC) ALTER BIOLOGICAL MARKERS IN LOCALLY ADVANCED BREAST-CANCER (LABC), Laboratory investigation, 74(1), 1996, pp. 121-121
GROSS AND HISTOLOGIC FEATURES OF LOCALLY ADVANCED BREAST-CANCER (LABC) AFTER NEOADJUVANT CHEMOTHERAPY (NAC)
Authors: SENO R SPARANO JA FINEBERG S
Citation: R. Seno et al., GROSS AND HISTOLOGIC FEATURES OF LOCALLY ADVANCED BREAST-CANCER (LABC) AFTER NEOADJUVANT CHEMOTHERAPY (NAC), Laboratory investigation, 74(1), 1996, pp. 122-122
RHABDOMYOLYSIS - AN UNUSUAL COMPLICATION OF CYTOTOXIC CHEMOTHERAPY
Authors: LEVY RJ SPARANO JA KHAN G
Citation: Rj. Levy et al., RHABDOMYOLYSIS - AN UNUSUAL COMPLICATION OF CYTOTOXIC CHEMOTHERAPY, Medical oncology, 12(4), 1995, pp. 219-222
PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES
Authors: KHALIL A CIOBANU N SPARANO JA GUCALP R DUTCHER JP WIERNIK PH
Citation: A. Khalil et al., PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES, Bone marrow transplantation, 15(1), 1995, pp. 93-97
ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY
Authors: COBLEIGH MA BERRIS RF BUSH T DAVIDSON NE ROBERT NJ SPARANO JA TORMEY DC WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY, JAMA, the journal of the American Medical Association, 273(8), 1995, pp. 621-621
ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994)
Authors: COBLEIGH MA BERRIS RF BUSH T DAVIDSON NE ROBERT NJ SPARANO JA TORMEY DC WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994), JAMA, the journal of the American Medical Association, 273(5), 1995, pp. 378-378
EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER
Authors: SLEDGE GW ROBERT N SPARANO JA COGLEIGH M GOLDSTEIN LJ NEUBERG D ROWINSKY E BAUGHMAN C MCCASKILLSTEVENS W
Citation: Gw. Sledge et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER, Seminars in oncology, 22(3), 1995, pp. 105-108
STEREOTAXIC BREAST CORE-NEEDLE BIOPSY OF MULTIPLE SITES - EFFICACY AND IMPACT ON MANAGEMENT
Authors: ROSENBLATT R FEINBERG SA SPARANO JA KALEYA RN
Citation: R. Rosenblatt et al., STEREOTAXIC BREAST CORE-NEEDLE BIOPSY OF MULTIPLE SITES - EFFICACY AND IMPACT ON MANAGEMENT, Radiology, 197, 1995, pp. 407-408
DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
Authors: SPARANO JA WIERNIK PH HU X DUTCHER JP SARTA C HENRY D MASON B
Citation: Ja. Sparano et al., DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), Blood, 86(10), 1995, pp. 3724-3724
ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER
Authors: WIERNIK PH SKLARIN NT DUTCHER JP SPARANO JA GREENWALD ES
Citation: Ph. Wiernik et al., ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER, Medical oncology, 11(3-4), 1994, pp. 121-125
IMMUNOLOGICAL THERAPY OF BREAST-CANCER - CURRENT STATUS AND FUTURE POTENTIAL
Authors: SPARANO JA OBOYLE K
Citation: Ja. Sparano et K. Oboyle, IMMUNOLOGICAL THERAPY OF BREAST-CANCER - CURRENT STATUS AND FUTURE POTENTIAL, CLINICAL IMMUNOTHERAPEUTICS, 1(2), 1994, pp. 135-147
PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
Authors: SPARANO JA FISHER RI WEISS GR MARGOLIN K ARONSON FR HAWKINS MJ ATKINS MB DUTCHER JP GAYNOR ER BOLDT DH DOROSHOW JH ERNEST ML SZNOL M MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
Risultati: 1-25 | 26-39